aluates Reports

$ 0.0

Automative

Global Microphysiological System and Organoids Market Research Report 2026

Published Date: 2026-03-27

Report Code: QYRE-Auto-10X17346

Global Microphysiological System and Organoids Market Research Report 2024

BUY CHAPTERS

Global Microphysiological System and Organoids Market Research Report 2026

Code: QYRE-Auto-10X17346

Report

2026-03-27

Pages:168

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Emulate

Mimetas

Insphero

Tissuse

Cn Bio

Hesperos

TNO

AxoSim

Newcells Biotech

Nortis

Netri

Draper Laboratory

Beijing Daxiang Biotech

Altis Biosystems

Cherry Biotech

Bi/ond

Ananda Devices

ImmuONE

React4life

AlveoliX

BiomimX

Aracari Bio

StemPharm

Synvivo

Valo Health (TARA Biosystems)

Obatala Sciences

Microphysiological System and Organoids Market Size

The global Microphysiological System and Organoids market was valued at US$ 150 million in 2025 and is anticipated to reach US$ 424 million by 2032, at a CAGR of 16.2% from 2026 to 2032.

Microphysiological System and Organoids Market

Microphysiological systems (MPS), also known as organ-on-a-chip systems, and organoids are innovative technologies used in biomedical research to model human physiology and diseases in vitro. MPS are microscale platforms that mimic the structure and function of human organs or tissues, typically incorporating cells, scaffolds, and microfluidic channels to create microenvironments that replicate physiological conditions. Organoids, on the other hand, are three-dimensional clusters of cells grown from stem cells or tissue samples that self-organize and differentiate into structures resembling specific organs. These systems offer unique advantages for studying human biology and disease mechanisms, enabling researchers to recapitulate complex tissue architecture and cellular interactions in a controlled laboratory setting. MPS and organoids hold great promise for drug discovery, toxicity testing, disease modeling, and personalized medicine applications, facilitating the development of more effective therapies and treatments.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.

Due to better policy and financial support in European countries and USA and earlier research, the overall industry of microphysiological system has developed rapidly, and the industrialization process in other regions such as Asia is lagging behind.

It is worth noting that because the microphysiological system industry is still in the early stages of development, and the mid-stream and downstream demand has not yet increased, many microphysiological system companies play an upstream role to some extent and mostly conduct organoid and organ-on-chip research on their own. Research and development of chip automation, high-throughput operating instruments and imaging equipment.

With the further development of the industry in the future and the implementation of relevant policies and standards, the industry's demand for upstream will increase, which will promote the birth of more professional upstream companies and the business transformation of some microphysiological system companies.

This report delivers a comprehensive overview of the global Microphysiological System and Organoids market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Microphysiological System and Organoids. The Microphysiological System and Organoids market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Microphysiological System and Organoids market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Microphysiological System and Organoids manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Microphysiological System and Organoids Market Report

Report Metric	Details
Report Name	Microphysiological System and Organoids Market
Accounted market size in 2025	US$ 150 million
Forecasted market size in 2032	US$ 424 million
CAGR	16.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Human Organ and Tissue Models Disease Models Non-Human Species Models
Segment by Application	Pharmaceutical & Biotechnology Companies Academic & Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, AxoSim, Newcells Biotech, Nortis, Netri, Draper Laboratory, Beijing Daxiang Biotech, Altis Biosystems, Cherry Biotech, Bi/ond, Obatala Sciences, Ananda Devices, ImmuONE, React4life, AlveoliX, BiomimX, Aracari Bio, StemPharm, SynVivo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Microphysiological System and Organoids companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Microphysiological System and Organoids Market growing?

Ans: The Microphysiological System and Organoids Market witnessing a CAGR of 16.2% during the forecast period 2026-2032.

What is the Microphysiological System and Organoids Market size in 2032?

Ans: The Microphysiological System and Organoids Market size in 2032 will be US$ 424 million.

Who are the main players in the Microphysiological System and Organoids Market report?

Ans: The main players in the Microphysiological System and Organoids Market are Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, AxoSim, Newcells Biotech, Nortis, Netri, Draper Laboratory, Beijing Daxiang Biotech, Altis Biosystems, Cherry Biotech, Bi/ond, Obatala Sciences, Ananda Devices, ImmuONE, React4life, AlveoliX, BiomimX, Aracari Bio, StemPharm, SynVivo

What are the Application segmentation covered in the Microphysiological System and Organoids Market report?

Ans: The Applications covered in the Microphysiological System and Organoids Market report are Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others

What are the Type segmentation covered in the Microphysiological System and Organoids Market report?

Ans: The Types covered in the Microphysiological System and Organoids Market report are Human Organ and Tissue Models, Disease Models, Non-Human Species Models

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microphysiological System and Organoids Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Human Organ and Tissue Models

1.2.3 Disease Models

1.2.4 Non-Human Species Models

1.3 Market by Application

1.3.1 Global Microphysiological System and Organoids Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Academic & Research Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microphysiological System and Organoids Market Perspective (2021–2032)

2.2 Global Microphysiological System and Organoids Growth Trends by Region

2.2.1 Global Microphysiological System and Organoids Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Microphysiological System and Organoids Historic Market Size by Region (2021–2026)

2.2.3 Microphysiological System and Organoids Forecasted Market Size by Region (2027–2032)

2.3 Microphysiological System and Organoids Market Dynamics

2.3.1 Microphysiological System and Organoids Industry Trends

2.3.2 Microphysiological System and Organoids Market Drivers

2.3.3 Microphysiological System and Organoids Market Challenges

2.3.4 Microphysiological System and Organoids Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microphysiological System and Organoids Players by Revenue

3.1.1 Global Top Microphysiological System and Organoids Players by Revenue (2021–2026)

3.1.2 Global Microphysiological System and Organoids Revenue Market Share by Players (2021–2026)

3.2 Global Top Microphysiological System and Organoids Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Microphysiological System and Organoids Revenue

3.4 Global Microphysiological System and Organoids Market Concentration Ratio

3.4.1 Global Microphysiological System and Organoids Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microphysiological System and Organoids Revenue in 2025

3.5 Global Key Players of Microphysiological System and Organoids Head Offices and Areas Served

3.6 Global Key Players of Microphysiological System and Organoids, Products and Applications

3.7 Global Key Players of Microphysiological System and Organoids, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Microphysiological System and Organoids Breakdown Data by Type

4.1 Global Microphysiological System and Organoids Historic Market Size by Type (2021–2026)

4.2 Global Microphysiological System and Organoids Forecasted Market Size by Type (2027–2032)

5 Microphysiological System and Organoids Breakdown Data by Application

5.1 Global Microphysiological System and Organoids Historic Market Size by Application (2021–2026)

5.2 Global Microphysiological System and Organoids Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Microphysiological System and Organoids Market Size (2021–2032)

6.2 North America Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Microphysiological System and Organoids Market Size by Country (2021–2026)

6.4 North America Microphysiological System and Organoids Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microphysiological System and Organoids Market Size (2021–2032)

7.2 Europe Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Microphysiological System and Organoids Market Size by Country (2021–2026)

7.4 Europe Microphysiological System and Organoids Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Microphysiological System and Organoids Market Size (2021–2032)

8.2 Asia-Pacific Microphysiological System and Organoids Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Microphysiological System and Organoids Market Size by Region (2021–2026)

8.4 Asia-Pacific Microphysiological System and Organoids Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Microphysiological System and Organoids Market Size (2021–2032)

9.2 Latin America Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Microphysiological System and Organoids Market Size by Country (2021–2026)

9.4 Latin America Microphysiological System and Organoids Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microphysiological System and Organoids Market Size (2021–2032)

10.2 Middle East & Africa Microphysiological System and Organoids Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Microphysiological System and Organoids Market Size by Country (2021–2026)

10.4 Middle East & Africa Microphysiological System and Organoids Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emulate

11.1.1 Emulate Company Details

11.1.2 Emulate Business Overview

11.1.3 Emulate Microphysiological System and Organoids Introduction

11.1.4 Emulate Revenue in Microphysiological System and Organoids Business (2021–2026)

11.1.5 Emulate Recent Development

11.2 Mimetas

11.2.1 Mimetas Company Details

11.2.2 Mimetas Business Overview

11.2.3 Mimetas Microphysiological System and Organoids Introduction

11.2.4 Mimetas Revenue in Microphysiological System and Organoids Business (2021–2026)

11.2.5 Mimetas Recent Development

11.3 InSphero

11.3.1 InSphero Company Details

11.3.2 InSphero Business Overview

11.3.3 InSphero Microphysiological System and Organoids Introduction

11.3.4 InSphero Revenue in Microphysiological System and Organoids Business (2021–2026)

11.3.5 InSphero Recent Development

11.4 TissUse

11.4.1 TissUse Company Details

11.4.2 TissUse Business Overview

11.4.3 TissUse Microphysiological System and Organoids Introduction

11.4.4 TissUse Revenue in Microphysiological System and Organoids Business (2021–2026)

11.4.5 TissUse Recent Development

11.5 CN Bio

11.5.1 CN Bio Company Details

11.5.2 CN Bio Business Overview

11.5.3 CN Bio Microphysiological System and Organoids Introduction

11.5.4 CN Bio Revenue in Microphysiological System and Organoids Business (2021–2026)

11.5.5 CN Bio Recent Development

11.6 Valo Health (TARA Biosystems)

11.6.1 Valo Health (TARA Biosystems) Company Details

11.6.2 Valo Health (TARA Biosystems) Business Overview

11.6.3 Valo Health (TARA Biosystems) Microphysiological System and Organoids Introduction

11.6.4 Valo Health (TARA Biosystems) Revenue in Microphysiological System and Organoids Business (2021–2026)

11.6.5 Valo Health (TARA Biosystems) Recent Development

11.7 Hesperos

11.7.1 Hesperos Company Details

11.7.2 Hesperos Business Overview

11.7.3 Hesperos Microphysiological System and Organoids Introduction

11.7.4 Hesperos Revenue in Microphysiological System and Organoids Business (2021–2026)

11.7.5 Hesperos Recent Development

11.8 TNO

11.8.1 TNO Company Details

11.8.2 TNO Business Overview

11.8.3 TNO Microphysiological System and Organoids Introduction

11.8.4 TNO Revenue in Microphysiological System and Organoids Business (2021–2026)

11.8.5 TNO Recent Development

11.9 AxoSim

11.9.1 AxoSim Company Details

11.9.2 AxoSim Business Overview

11.9.3 AxoSim Microphysiological System and Organoids Introduction

11.9.4 AxoSim Revenue in Microphysiological System and Organoids Business (2021–2026)

11.9.5 AxoSim Recent Development

11.10 Newcells Biotech

11.10.1 Newcells Biotech Company Details

11.10.2 Newcells Biotech Business Overview

11.10.3 Newcells Biotech Microphysiological System and Organoids Introduction

11.10.4 Newcells Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)

11.10.5 Newcells Biotech Recent Development

11.11 Nortis

11.11.1 Nortis Company Details

11.11.2 Nortis Business Overview

11.11.3 Nortis Microphysiological System and Organoids Introduction

11.11.4 Nortis Revenue in Microphysiological System and Organoids Business (2021–2026)

11.11.5 Nortis Recent Development

11.12 Netri

11.12.1 Netri Company Details

11.12.2 Netri Business Overview

11.12.3 Netri Microphysiological System and Organoids Introduction

11.12.4 Netri Revenue in Microphysiological System and Organoids Business (2021–2026)

11.12.5 Netri Recent Development

11.13 Draper Laboratory

11.13.1 Draper Laboratory Company Details

11.13.2 Draper Laboratory Business Overview

11.13.3 Draper Laboratory Microphysiological System and Organoids Introduction

11.13.4 Draper Laboratory Revenue in Microphysiological System and Organoids Business (2021–2026)

11.13.5 Draper Laboratory Recent Development

11.14 Beijing Daxiang Biotech

11.14.1 Beijing Daxiang Biotech Company Details

11.14.2 Beijing Daxiang Biotech Business Overview

11.14.3 Beijing Daxiang Biotech Microphysiological System and Organoids Introduction

11.14.4 Beijing Daxiang Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)

11.14.5 Beijing Daxiang Biotech Recent Development

11.15 Altis Biosystems

11.15.1 Altis Biosystems Company Details

11.15.2 Altis Biosystems Business Overview

11.15.3 Altis Biosystems Microphysiological System and Organoids Introduction

11.15.4 Altis Biosystems Revenue in Microphysiological System and Organoids Business (2021–2026)

11.15.5 Altis Biosystems Recent Development

11.16 Cherry Biotech

11.16.1 Cherry Biotech Company Details

11.16.2 Cherry Biotech Business Overview

11.16.3 Cherry Biotech Microphysiological System and Organoids Introduction

11.16.4 Cherry Biotech Revenue in Microphysiological System and Organoids Business (2021–2026)

11.16.5 Cherry Biotech Recent Development

11.17 Bi/ond

11.17.1 Bi/ond Company Details

11.17.2 Bi/ond Business Overview

11.17.3 Bi/ond Microphysiological System and Organoids Introduction

11.17.4 Bi/ond Revenue in Microphysiological System and Organoids Business (2021–2026)

11.17.5 Bi/ond Recent Development

11.18 Obatala Sciences

11.18.1 Obatala Sciences Company Details

11.18.2 Obatala Sciences Business Overview

11.18.3 Obatala Sciences Microphysiological System and Organoids Introduction

11.18.4 Obatala Sciences Revenue in Microphysiological System and Organoids Business (2021–2026)

11.18.5 Obatala Sciences Recent Development

11.19 Ananda Devices

11.19.1 Ananda Devices Company Details

11.19.2 Ananda Devices Business Overview

11.19.3 Ananda Devices Microphysiological System and Organoids Introduction

11.19.4 Ananda Devices Revenue in Microphysiological System and Organoids Business (2021–2026)

11.19.5 Ananda Devices Recent Development

11.20 ImmuONE

11.20.1 ImmuONE Company Details

11.20.2 ImmuONE Business Overview

11.20.3 ImmuONE Microphysiological System and Organoids Introduction

11.20.4 ImmuONE Revenue in Microphysiological System and Organoids Business (2021–2026)

11.20.5 ImmuONE Recent Development

11.21 React4life

11.21.1 React4life Company Details

11.21.2 React4life Business Overview

11.21.3 React4life Microphysiological System and Organoids Introduction

11.21.4 React4life Revenue in Microphysiological System and Organoids Business (2021–2026)

11.21.5 React4life Recent Development

11.22 AlveoliX

11.22.1 AlveoliX Company Details

11.22.2 AlveoliX Business Overview

11.22.3 AlveoliX Microphysiological System and Organoids Introduction

11.22.4 AlveoliX Revenue in Microphysiological System and Organoids Business (2021–2026)

11.22.5 AlveoliX Recent Development

11.23 BiomimX

11.23.1 BiomimX Company Details

11.23.2 BiomimX Business Overview

11.23.3 BiomimX Microphysiological System and Organoids Introduction

11.23.4 BiomimX Revenue in Microphysiological System and Organoids Business (2021–2026)

11.23.5 BiomimX Recent Development

11.24 Aracari Bio

11.24.1 Aracari Bio Company Details

11.24.2 Aracari Bio Business Overview

11.24.3 Aracari Bio Microphysiological System and Organoids Introduction

11.24.4 Aracari Bio Revenue in Microphysiological System and Organoids Business (2021–2026)

11.24.5 Aracari Bio Recent Development

11.25 StemPharm

11.25.1 StemPharm Company Details

11.25.2 StemPharm Business Overview

11.25.3 StemPharm Microphysiological System and Organoids Introduction

11.25.4 StemPharm Revenue in Microphysiological System and Organoids Business (2021–2026)

11.25.5 StemPharm Recent Development

11.26 SynVivo

11.26.1 SynVivo Company Details

11.26.2 SynVivo Business Overview

11.26.3 SynVivo Microphysiological System and Organoids Introduction

11.26.4 SynVivo Revenue in Microphysiological System and Organoids Business (2021–2026)

11.26.5 SynVivo Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Emulate

Mimetas

Insphero

Tissuse

Cn Bio

Hesperos

TNO

AxoSim

Newcells Biotech

Nortis

Netri

Draper Laboratory

Beijing Daxiang Biotech

Altis Biosystems

Cherry Biotech

Bi/ond

Ananda Devices

ImmuONE

React4life

AlveoliX

BiomimX

Aracari Bio

StemPharm

Synvivo

Valo Health (TARA Biosystems)

Obatala Sciences

List of Tables

Table 1. Global Microphysiological System and Organoids Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Human Organ and Tissue Models

Table 3. Key Players of Disease Models

Table 4. Key Players of Non-Human Species Models

Table 5. Global Microphysiological System and Organoids Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Microphysiological System and Organoids Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Microphysiological System and Organoids Market Size by Region (US$ Million), 2021–2026

Table 8. Global Microphysiological System and Organoids Market Share by Region (2021–2026)

Table 9. Global Microphysiological System and Organoids Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Microphysiological System and Organoids Market Share by Region (2027–2032)

Table 11. Microphysiological System and Organoids Market Trends

Table 12. Microphysiological System and Organoids Market Drivers

Table 13. Microphysiological System and Organoids Market Challenges

Table 14. Microphysiological System and Organoids Market Restraints

Table 15. Global Microphysiological System and Organoids Revenue by Players (US$ Million), 2021–2026

Table 16. Global Microphysiological System and Organoids Market Share by Players (2021–2026)

Table 17. Global Top Microphysiological System and Organoids Players by Tier (Tier 1, Tier 2, and Tier 3), based on Microphysiological System and Organoids Revenue, 2025

Table 18. Ranking of Global Top Microphysiological System and Organoids Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Microphysiological System and Organoids Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Microphysiological System and Organoids, Headquarters and Area Served

Table 21. Global Key Players of Microphysiological System and Organoids, Products and Applications

Table 22. Global Key Players of Microphysiological System and Organoids, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Microphysiological System and Organoids Market Size by Type (US$ Million), 2021–2026

Table 25. Global Microphysiological System and Organoids Revenue Market Share by Type (2021–2026)

Table 26. Global Microphysiological System and Organoids Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Microphysiological System and Organoids Revenue Market Share by Type (2027–2032)

Table 28. Global Microphysiological System and Organoids Market Size by Application (US$ Million), 2021–2026

Table 29. Global Microphysiological System and Organoids Revenue Market Share by Application (2021–2026)

Table 30. Global Microphysiological System and Organoids Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Microphysiological System and Organoids Revenue Market Share by Application (2027–2032)

Table 32. North America Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026

Table 34. North America Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Microphysiological System and Organoids Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Microphysiological System and Organoids Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Microphysiological System and Organoids Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Microphysiological System and Organoids Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Microphysiological System and Organoids Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Microphysiological System and Organoids Market Size by Country (US$ Million), 2027–2032

Table 47. Emulate Company Details

Table 48. Emulate Business Overview

Table 49. Emulate Microphysiological System and Organoids Product

Table 50. Emulate Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 51. Emulate Recent Development

Table 52. Mimetas Company Details

Table 53. Mimetas Business Overview

Table 54. Mimetas Microphysiological System and Organoids Product

Table 55. Mimetas Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 56. Mimetas Recent Development

Table 57. InSphero Company Details

Table 58. InSphero Business Overview

Table 59. InSphero Microphysiological System and Organoids Product

Table 60. InSphero Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 61. InSphero Recent Development

Table 62. TissUse Company Details

Table 63. TissUse Business Overview

Table 64. TissUse Microphysiological System and Organoids Product

Table 65. TissUse Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 66. TissUse Recent Development

Table 67. CN Bio Company Details

Table 68. CN Bio Business Overview

Table 69. CN Bio Microphysiological System and Organoids Product

Table 70. CN Bio Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 71. CN Bio Recent Development

Table 72. Valo Health (TARA Biosystems) Company Details

Table 73. Valo Health (TARA Biosystems) Business Overview

Table 74. Valo Health (TARA Biosystems) Microphysiological System and Organoids Product

Table 75. Valo Health (TARA Biosystems) Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 76. Valo Health (TARA Biosystems) Recent Development

Table 77. Hesperos Company Details

Table 78. Hesperos Business Overview

Table 79. Hesperos Microphysiological System and Organoids Product

Table 80. Hesperos Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 81. Hesperos Recent Development

Table 82. TNO Company Details

Table 83. TNO Business Overview

Table 84. TNO Microphysiological System and Organoids Product

Table 85. TNO Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 86. TNO Recent Development

Table 87. AxoSim Company Details

Table 88. AxoSim Business Overview

Table 89. AxoSim Microphysiological System and Organoids Product

Table 90. AxoSim Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 91. AxoSim Recent Development

Table 92. Newcells Biotech Company Details

Table 93. Newcells Biotech Business Overview

Table 94. Newcells Biotech Microphysiological System and Organoids Product

Table 95. Newcells Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 96. Newcells Biotech Recent Development

Table 97. Nortis Company Details

Table 98. Nortis Business Overview

Table 99. Nortis Microphysiological System and Organoids Product

Table 100. Nortis Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 101. Nortis Recent Development

Table 102. Netri Company Details

Table 103. Netri Business Overview

Table 104. Netri Microphysiological System and Organoids Product

Table 105. Netri Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 106. Netri Recent Development

Table 107. Draper Laboratory Company Details

Table 108. Draper Laboratory Business Overview

Table 109. Draper Laboratory Microphysiological System and Organoids Product

Table 110. Draper Laboratory Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 111. Draper Laboratory Recent Development

Table 112. Beijing Daxiang Biotech Company Details

Table 113. Beijing Daxiang Biotech Business Overview

Table 114. Beijing Daxiang Biotech Microphysiological System and Organoids Product

Table 115. Beijing Daxiang Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 116. Beijing Daxiang Biotech Recent Development

Table 117. Altis Biosystems Company Details

Table 118. Altis Biosystems Business Overview

Table 119. Altis Biosystems Microphysiological System and Organoids Product

Table 120. Altis Biosystems Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 121. Altis Biosystems Recent Development

Table 122. Cherry Biotech Company Details

Table 123. Cherry Biotech Business Overview

Table 124. Cherry Biotech Microphysiological System and Organoids Product

Table 125. Cherry Biotech Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 126. Cherry Biotech Recent Development

Table 127. Bi/ond Company Details

Table 128. Bi/ond Business Overview

Table 129. Bi/ond Microphysiological System and Organoids Product

Table 130. Bi/ond Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 131. Bi/ond Recent Development

Table 132. Obatala Sciences Company Details

Table 133. Obatala Sciences Business Overview

Table 134. Obatala Sciences Microphysiological System and Organoids Product

Table 135. Obatala Sciences Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 136. Obatala Sciences Recent Development

Table 137. Ananda Devices Company Details

Table 138. Ananda Devices Business Overview

Table 139. Ananda Devices Microphysiological System and Organoids Product

Table 140. Ananda Devices Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 141. Ananda Devices Recent Development

Table 142. ImmuONE Company Details

Table 143. ImmuONE Business Overview

Table 144. ImmuONE Microphysiological System and Organoids Product

Table 145. ImmuONE Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 146. ImmuONE Recent Development

Table 147. React4life Company Details

Table 148. React4life Business Overview

Table 149. React4life Microphysiological System and Organoids Product

Table 150. React4life Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 151. React4life Recent Development

Table 152. AlveoliX Company Details

Table 153. AlveoliX Business Overview

Table 154. AlveoliX Microphysiological System and Organoids Product

Table 155. AlveoliX Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 156. AlveoliX Recent Development

Table 157. BiomimX Company Details

Table 158. BiomimX Business Overview

Table 159. BiomimX Microphysiological System and Organoids Product

Table 160. BiomimX Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 161. BiomimX Recent Development

Table 162. Aracari Bio Company Details

Table 163. Aracari Bio Business Overview

Table 164. Aracari Bio Microphysiological System and Organoids Product

Table 165. Aracari Bio Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 166. Aracari Bio Recent Development

Table 167. StemPharm Company Details

Table 168. StemPharm Business Overview

Table 169. StemPharm Microphysiological System and Organoids Product

Table 170. StemPharm Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 171. StemPharm Recent Development

Table 172. SynVivo Company Details

Table 173. SynVivo Business Overview

Table 174. SynVivo Microphysiological System and Organoids Product

Table 175. SynVivo Revenue in Microphysiological System and Organoids Business (US$ Million), 2021–2026

Table 176. SynVivo Recent Development

Table 177. Research Programs/Design for This Report

Table 178. Key Data Information from Secondary Sources

Table 179. Key Data Information from Primary Sources

Table 180. Authors List of This Report

List of Figures

Figure 1. Microphysiological System and Organoids Picture

Figure 2. Global Microphysiological System and Organoids Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Microphysiological System and Organoids Market Share by Type: 2025 vs 2032

Figure 4. Human Organ and Tissue Models Features

Figure 5. Disease Models Features

Figure 6. Non-Human Species Models Features

Figure 7. Global Microphysiological System and Organoids Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Microphysiological System and Organoids Market Share by Application: 2025 vs 2032

Figure 9. Pharmaceutical & Biotechnology Companies Case Studies

Figure 10. Academic & Research Institutes Case Studies

Figure 11. Others Case Studies

Figure 12. Microphysiological System and Organoids Report Years Considered

Figure 13. Global Microphysiological System and Organoids Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Microphysiological System and Organoids Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Microphysiological System and Organoids Market Share by Region: 2025 vs 2032

Figure 16. Global Microphysiological System and Organoids Market Share by Players in 2025

Figure 17. Global Microphysiological System and Organoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Microphysiological System and Organoids Revenue in 2025

Figure 19. North America Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Microphysiological System and Organoids Market Share by Country (2021–2032)

Figure 21. United States Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Microphysiological System and Organoids Market Share by Country (2021–2032)

Figure 25. Germany Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Microphysiological System and Organoids Market Share by Region (2021–2032)

Figure 33. China Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Microphysiological System and Organoids Market Share by Country (2021–2032)

Figure 41. Mexico Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Microphysiological System and Organoids Market Share by Country (2021–2032)

Figure 45. Israel Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Microphysiological System and Organoids Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Emulate Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 49. Mimetas Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 50. InSphero Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 51. TissUse Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 52. CN Bio Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 53. Valo Health (TARA Biosystems) Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 54. Hesperos Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 55. TNO Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 56. AxoSim Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 57. Newcells Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 58. Nortis Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 59. Netri Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 60. Draper Laboratory Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 61. Beijing Daxiang Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 62. Altis Biosystems Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 63. Cherry Biotech Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 64. Bi/ond Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 65. Obatala Sciences Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 66. Ananda Devices Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 67. ImmuONE Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 68. React4life Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 69. AlveoliX Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 70. BiomimX Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 71. Aracari Bio Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 72. StemPharm Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 73. SynVivo Revenue Growth Rate in Microphysiological System and Organoids Business (2021–2026)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Microfluidic Devices For MPS Microphysiological Systems Market Research Report 2025

Global Organ Physiological Microsystem Market Research Report 2024

Organoids on Chips Model Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Organ Chip Simulation Simulation Culture System Market Research Report 2024

Global Organoid Models Market Research Report 2024

Global Organ Chips Market Research Report 2025

Human Organs on Chips Model Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Healthcare Microelectromechanical System Market Research Report 2024

Global Artificial Tissue Chips Market Research Report 2025

3D Cell Culture and Organ on a chip Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cardiac on a Chip Market Research Report 2024

Global Organoids and 3D Cell Culture Media Market Research Report 2024

Organoids Market

Global Brain on chip Model Market Research Report 2024

Global Organs on chips OOC Market Research Report 2024

Organ On Chip Market

Global Heart Organ Chip Market Research Report 2024

Human Organs on Chips Market

Global Organoid Biobank Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions